Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effect of exacerbations on lung density in α1-antitrypsin deficiency.
Strange C, McElvaney NG, Vogelmeier CF, Marin-Galiano M, Buch-Haensel M, Zhang X, Chen Y, Vit O, Wencker M, Chapman KR. Strange C, et al. Among authors: wencker m. ERJ Open Res. 2023 Mar 13;9(2):00457-2022. doi: 10.1183/23120541.00457-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 36923570 Free PMC article.
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
McElvaney NG, Burdon J, Holmes M, Glanville A, Wark PA, Thompson PJ, Hernandez P, Chlumsky J, Teschler H, Ficker JH, Seersholm N, Altraja A, Mäkitaro R, Chorostowska-Wynimko J, Sanak M, Stoicescu PI, Piitulainen E, Vit O, Wencker M, Tortorici MA, Fries M, Edelman JM, Chapman KR; RAPID Extension Trial Group. McElvaney NG, et al. Among authors: wencker m. Lancet Respir Med. 2017 Jan;5(1):51-60. doi: 10.1016/S2213-2600(16)30430-1. Epub 2016 Dec 2. Lancet Respir Med. 2017. PMID: 27916480 Clinical Trial.
Safety of biweekly α1-antitrypsin treatment in the RAPID programme.
Greulich T, Chlumsky J, Wencker M, Vit O, Fries M, Chung T, Shebl A, Vogelmeier C, Chapman KR, McElvaney NG; RAPID Trial Group. Greulich T, et al. Among authors: wencker m. Eur Respir J. 2018 Nov 29;52(5):1800897. doi: 10.1183/13993003.00897-2018. Print 2018 Nov. Eur Respir J. 2018. PMID: 30237305 Free PMC article. Clinical Trial.
The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
Schmid ST, Koepke J, Dresel M, Hattesohl A, Frenzel E, Perez J, Lomas DA, Miranda E, Greulich T, Noeske S, Wencker M, Teschler H, Vogelmeier C, Janciauskiene S, Koczulla AR. Schmid ST, et al. Among authors: wencker m. Int J Chron Obstruct Pulmon Dis. 2012;7:687-96. doi: 10.2147/COPD.S34560. Epub 2012 Sep 28. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 23055718 Free PMC article.
Imaging in alpha-1 antitrypsin deficiency: a window into the disease.
Huang YT, Wencker M, Driehuys B. Huang YT, et al. Among authors: wencker m. Ther Adv Chronic Dis. 2021 Jul 29;12_suppl:20406223211024523. doi: 10.1177/20406223211024523. eCollection 2021. Ther Adv Chronic Dis. 2021. PMID: 34408834 Free PMC article. Review.
Detection of obstructive sleep apnoea by an electronic nose.
Greulich T, Hattesohl A, Grabisch A, Koepke J, Schmid S, Noeske S, Nell C, Wencker M, Jörres RA, Vogelmeier CF, Köhler U, Koczulla AR. Greulich T, et al. Among authors: wencker m. Eur Respir J. 2013 Jul;42(1):145-55. doi: 10.1183/09031936.00091712. Epub 2012 Oct 25. Eur Respir J. 2013. PMID: 23100503 Free article.
65 results